Company Filing History:

9 out of 2,198

Smithkline Beecham Corporation

patents

4 out of 676

Human Genome Sciences, Inc.

patents

2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2006

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7138498 - Antibodies to MCP-4 (2006-11-21),

2. 6936688 - Human chemokine beta-10 mutant polypeptides (2005-08-30),

3. 6713052 - Method of mobilizing stem cells with chemokine &bgr;-8 (2004-03-30),

4. 6673344 - Antibodies to human CK&bgr;-10/MCP-4 (2004-01-06),

5. 6645989 - Compounds (2003-11-11),

6. 6420424 - CCR-3 receptor antagonists (2002-07-16),

7. 6406688 - Method of treating sepsis and ARDS with chemokine &bgr;-4 (2002-06-18),

8. 6391589 - Human chemokine beta-10 mutant polypeptides (2002-05-21),

9. 6290948 - Method of treating sepsis and ARDS using chamohine beta-10 (2001-09-18),

10. 6268370 - Compounds (2001-07-31),

11. 6153441 - Methods of screening for agonists and antagonists for human CCR7 (2000-11-28),

12. 5916891 - Pyrimidinyl imidazoles (1999-06-29),

13. 5686455 - Imidazole derivatives and their use as cytokine inhibitors (1997-11-11),

14. 5656644 - Pyridyl imidazoles (1997-08-12),

Title: Innovations and Contributions of John Richard White

Introduction

John Richard White is a notable inventor based in Coatesville, Pennsylvania. He has made significant contributions to the field of biotechnology, particularly in the development of chemokine polypeptides and their therapeutic applications. With a total of 14 patents to his name, White's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, White has developed antibodies to MCP-4, which include human chemokine polypeptides and DNA (RNA) encoding such polypeptides. His work discloses a procedure for producing these polypeptides through recombinant techniques. Furthermore, he has outlined methods for utilizing these chemokine polypeptides in the treatment of leukemia, tumors, chronic infections, autoimmune diseases, fibrotic disorders, wound healing, and psoriasis. Additionally, he has disclosed antagonists against these chemokine polypeptides, which can be used therapeutically to treat rheumatoid arthritis, autoimmune and chronic inflammatory diseases, allergic reactions, prostaglandin-independent fever, and bone marrow failure. Another significant patent involves human chemokine beta-10 mutant polypeptides, which also includes methods for their production and therapeutic applications similar to those mentioned above.

Career Highlights

Throughout his career, John Richard White has worked with prominent companies in the biotechnology sector. Notably, he has been associated with SmithKline Beecham Corporation and Human Genome Sciences, Inc. His work in these organizations has contributed to advancements in genetic research and therapeutic development.

Collaborations

White has collaborated with several professionals in his field, including Jerry Leroy Adams and Timothy Francis Gallagher. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

John Richard White's innovative work in the field of biotechnology, particularly in the development of chemokine polypeptides, showcases his significant contributions to medical science. His patents reflect a commitment to addressing complex health issues through advanced research and collaboration.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.